HOPKINTON, Mass. and TOKYO, Aug. 9, 2024 /PRNewswire/ — Phosphorex, a drug delivery-focused contract development and manufacturing organization (“CDMO”) backed by Boston-based private equity firm Ampersand Capital Partners, announced today that NOF CORPORATION has completed a strategic…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.